We document and disseminate various results, trainings, and resources from our research, programs, and projects.
A twinning partnership is a formal and substantive collaboration between two districts to improve their performance in providing primary healthcare services. The ‘win-win’ twinning partnership pairs are categorized under relatively high and low-performing districts. The purpose of this formative evaluation is to use the empirically derived systems model as an analytical framework to systematically document…
Many people have questions about Pre-exposure prophylaxis (PrEP). This briefer answers frequently asked questions, from How often do I need to take PrEP? to What happens if I miss a pill? More than 20 commonly asked questions are answered in thie FAQ. JSI/AIDSfree project. 2020.
This is the second in a JSI series on child health – Beyond Survival. JSI’s approach to supporting the health of women and children is rooted in a life-course perspective and recognizes that biological, behavioral, environmental, and socioeconomic factors determine health outcomes. Health equity is therefore integral to our work. Michel Pacqué, JSI. 2020. Beyond…
Exposure to adversity in childhood is tied to a range of negative health and social outcomes across the life course. This issue touches individuals, families, and communities. Additionally, it reaches across sectors and fields, including public health, education, health care, the legal system, and child welfare. In recent years, there has been tremendous growth in…
There is a growing recognition that certain harmful experiences in childhood are associated with a range of negative health and social impacts throughout life. These experiences include abuse or neglect, having a family member who is incarcerated, and living in an environment of community violence, among others. Given the enduring effects of adverse experiences during…
In April 2018, Tanzania became the seventh African nation to introduce the Human Papillomavirus (HPV) vaccine into its routine immunization (RI) program, with the second dose administered to the first group of eligible girls in October 2018. This brief gives an overview of the HPV vaccine introduction process, highlighting key technical support provided as well…
From May 2017 through July 2020, JSI supported the Tanzania Immunization and Vaccine Development (IVD) unit with comprehensive planning and national rollout and monitoring of human papillomavirus (HPV) vaccination, including its use as part of the country’s routine immunization system. Community buy-in for HPV immunization has been essential for uptake. This brief describes the process…
This paper is one of two discussion papers commissioned to identify key issues and practices regarding the scientific evidence, and to summarize recent and current programmatic experiences; this paper serves as the second of these papers. The goal of this paper is to review the approaches used, practices promoted, and lessons learned by projects and…
This systematic literature review focuses on the identification of risk and protective factors – sociodemographic, behavioral and structural – associated with orphans’ and vulnerable children’s (OVC) likelihood of being or becoming HIV infected to inform the development of a high-yield community screening tool to identify at-risk OVC and link them to HIV testing services. The review examines the state of the…
Emerging HIV treatment distribution models across sub-Saharan Africa seek to overcome barriers to attaining antiretroviral therapy and to strengthen adherence in people living with HIV. We describe enablers, barriers, and benefits of differentiated treatment distribution models in South Africa, Uganda, and Zimbabwe. Data collection included semistructured interviews and focus group discussions with 163 stakeholders from…
We strive to build lasting relationships to produce better health outcomes for all.
